Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1982 1
1983 1
1984 1
1985 2
1986 2
1987 5
1988 1
1991 3
1992 5
1993 2
1994 1
1995 5
1996 3
1997 1
1998 2
1999 2
2000 5
2001 7
2002 4
2003 2
2004 5
2005 5
2006 3
2007 6
2008 9
2009 8
2010 11
2011 6
2012 7
2013 17
2014 16
2015 16
2016 9
2017 11
2018 15
2019 12
2020 15
2021 25
2022 29
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Results by year
Filters applied: . Clear all
Page 1
Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction.
Sukeishi A, Itohara K, Yonezawa A, Sato Y, Matsumura K, Katada Y, Nakagawa T, Hamada S, Tanabe N, Imoto E, Kai S, Hirai T, Yanagita M, Ohtsuru S, Terada T, Ito I. Sukeishi A, et al. Among authors: yonezawa a. CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):94-103. doi: 10.1002/psp4.12736. Epub 2021 Nov 18. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 34793625 Free PMC article.
Pronociceptive Roles of Schwann Cell-Derived Galectin-3 in Taxane-Induced Peripheral Neuropathy.
Koyanagi M, Imai S, Matsumoto M, Iguma Y, Kawaguchi-Sakita N, Kotake T, Iwamitsu Y, Ntogwa M, Hiraiwa R, Nagayasu K, Saigo M, Ogihara T, Yonezawa A, Omura T, Nakagawa S, Nakagawa T, Matsubara K. Koyanagi M, et al. Among authors: yonezawa a. Cancer Res. 2021 Apr 15;81(8):2207-2219. doi: 10.1158/0008-5472.CAN-20-2799. Epub 2021 Feb 19. Cancer Res. 2021. PMID: 33608316
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trial.
Muranushi H, Kanda J, Kobayashi M, Maeda T, Kitano T, Tsuji M, Ueda Y, Ishikawa T, Nohgawa M, Watanabe M, Imada K, Moriguchi T, Itoh M, Ohno H, Yonezawa A, Hirata H, Arima N, Asagoe K, Anzai N, Nagata K, Yasuno S, Kuwabara Y, Kitao H, Kim I, Kawagishi K, Ueshima K, Tominari S, Nakayama T, Yamashita K, Takaori-Kondo A. Muranushi H, et al. Among authors: yonezawa a. Hematology. 2022 Dec;27(1):239-248. doi: 10.1080/16078454.2022.2032915. Hematology. 2022. PMID: 35152852 Clinical Trial.
Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy.
Yonezawa A, Dutt S, Chester C, Kim J, Kohrt HE. Yonezawa A, et al. Clin Cancer Res. 2015 Jul 15;21(14):3113-20. doi: 10.1158/1078-0432.CCR-15-0263. Epub 2015 Apr 23. Clin Cancer Res. 2015. PMID: 25908780 Free PMC article. Review.
Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning.
Iwasaki M, Kanda J, Arai Y, Kondo T, Ishikawa T, Ueda Y, Imada K, Akasaka T, Yonezawa A, Yago K, Nohgawa M, Anzai N, Moriguchi T, Kitano T, Itoh M, Arima N, Takeoka T, Watanabe M, Hirata H, Asagoe K, Miyatsuka I, An LM, Miyanishi M, Takaori-Kondo A. Iwasaki M, et al. Among authors: yonezawa a. Blood Adv. 2022 Apr 26;6(8):2618-2627. doi: 10.1182/bloodadvances.2021005800. Blood Adv. 2022. PMID: 34933327 Free PMC article.
A Nationwide Questionnaire Survey on Awake Craniotomy in Japan.
Kawata M, Fukui A, Mineharu Y, Kikuchi T, Yamao Y, Yamamoto Hattori E, Shiraki A, Mizota T, Furukawa K, Miyamoto S, Yonezawa A, Arakawa Y. Kawata M, et al. Among authors: yonezawa a. Neurol Med Chir (Tokyo). 2022 Jun 15;62(6):278-285. doi: 10.2176/jns-nmc.2021-0290. Epub 2022 Mar 29. Neurol Med Chir (Tokyo). 2022. PMID: 35354712 Free PMC article.
251 results